查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827394

支架市场按产品类型、材料、交付方式、应用和最终用户划分—2025-2032 年全球预测

Stents Market by Product Type, Material, Mode of Delivery, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年支架市场规模将成长至 253.3 亿美元，复合年增长率为 7.73%。

主要市场统计数据
基准年2024年 139.5亿美元
预计2025年 150.1亿美元
预测年份：2032年 253.3亿美元
复合年增长率（%） 7.73%

关于临床创新、监管要求和医疗保健服务转变如何重塑支架和介入器材策略的简明策略概述

支架在介入医学、器材工程和卫生系统经济学的交叉领域中发挥着至关重要的作用。材料科学、手术技术和影像技术的进步，已将支架的治疗用途从冠状动脉介入扩展到神经血管、週边血管、胃肠道和泌尿器官系统。临床医师越来越青睐微创治疗，因为这些治疗方案恢復时间较短、併发症发生率更低，且可在门诊就诊，导致采购优先顺序和医疗服务模式重塑。

市场参与企业在复杂的监管和报销环境中运营，需要严格的临床证据和上市后监管。监管机构目前优先考虑长期安全性和实际应用效果，迫使製造商将资料生成功能整合到其产品策略中。同时，医疗保健服务体係正在探索基于价值的合约和与结果挂钩的采购模式，从而提高了比较临床效益和成本效益的标准。

本报告整合了技术、临床和商业性讯号，概述了创新在哪些领域创造差异化价值，以及营运压力如何推动策略调整。报告旨在为领导者提供清晰的现代动态基准，以便确定投资优先顺序、优化供应链并完善市场策略，从而满足不断变化的相关人员期望。

材料突破、设计演变和商业平台策略如何推动支架开发和临床应用的模式转移

在技​​术、法规和医疗保健服务整合的推动下，支架领域正在经历一场变革性的转变。随着我们从传统的不銹钢材料转向先进的合金和聚合物技术，支架的性能正在被材料创新所重新定义，这些技术能够提供更高的柔韧性、渗透性和生物相容性。这些材料的进步使得输送系统更薄、部署更精确，从而支持其扩展到具有挑战性的解剖适应症和复杂的患者群体。

同时，器械设计正日益与生理保护和血管再阻塞缓解紧密结合。药物释放型涂层、生物可吸收支架和表面工程技术旨在最大程度地减少新生内膜增生，同时保持血管完整性。这些设计趋势与改进的影像和导航工具相辅相成，这些工具有助于实现高度针对性的干预，并减少手术的变异性。器械性能与手术准确性之间的相互作用对训练、手术指南和临床实施具有重要意义。

在商业方面，供应商之间的整合以及与科技公司的策略联盟正在加速一种基于平台的模式，该模式将硬体与数据驱动服务相结合。保险报销模式正转向价值认可，鼓励製造商展现长期疗效，而不是只专注于与手术相关的指标。同时，门诊手术中心和专科诊所的日益普及，迫使製造商开发支援门诊工作流程的简化系统和服务模式。

监管机构正在加强上市后证据要求和真实世界数据收集，推动对综合登记和长期追踪的需求。为此，製造商正在投资数据基础设施、远端监控和相关人员参与策略。简而言之，该行业正在从单一产品创新转向整合材料、程序系统、数据和服务模式的整合解决方案，以展示临床和经济价值。

评估近期关税政策变化如何重塑整个医疗体系的支架供应链、製造足迹和商业采购动态

美国将于2025年推出新的关税政策，促使人们重新评估支架生态系统中的全球製造、采购和定价策略。由于进口关税影响零件和成品的经济效益，先前以成本和规模为目标的供应链正面临新的审查。这些关税压力正在加速供应商基础的多元化，并重新激发人们对区域製造的兴趣，以降低跨境贸易波动带来的风险。

虽然拥有垂直整合能力和灵活生产布局的製造商能够更轻鬆地适应变化，但依赖专业海外零件供应商的製造商正面临投入成本波动加剧的问题。为此，许多公司正在协商长期合同，将某些製造业务迁至更靠近终端市场的地方，并探索委託生产安排，以分摊固定成本并保持供应的连续性。这些商业动态正在改变资本配置决策，并影响研发投资的方向。

医院和医疗系统内的采购团队也正在调整筹资策略，以降低不断上升的转嫁成本。一些供应商正在重新调整其设备选择通讯协定，并进行更严格的合约谈判，而其他供应商则正在寻求集团采购安排，以保持对优先技术的使用。付款人和卫生技术评估人员正密切关注手术总成本及其对长期结果的影响，这加剧了对定价透明度和经过验证的价值提案的需求。

重要的是，关税环境正在奖励国内和近岸製造业投资，支持围绕医疗设备主权和供应链韧性的政策对话。同时，成本上升的环境可能会鼓励以材料效率、模组化製造和可重复使用模具为重点的渐进式创新。整体而言，关税变化的累积影响并非一次性衝击，而是推动整个支架产业采购、製造策略和商业性参与结构性转变的催化剂。

深入了解产品系列、材料选择、交付系统、临床用例和医疗保健环境如何影响技术采用和商业策略

细分市场动态揭示了产品类型、材料、交付方式、临床应用和最终用户环境的差异化需求驱动因素和独特的策略重点。产品种类繁多，涵盖专注于心肌重组的冠状动脉支架、旨在缓解管腔阻塞的胃肠道器械、用于颈动脉和颅内应用的神经血管支架、用于治疗颈动脉、股动脉、髂动脉和肾动脉疾病的外周支架，以及用于前列腺和输尿管疾病的泌尿系统系统支架。每个产品类别都有独特的操作要求、监管考虑和临床医生培训需求，这些都会影响产品的采用时间表和临床路径。

由钴铬合金、镍钛合金、铂铬合金和不銹钢等合金製成的金属支架，可为要求严格的血管区域提供可靠的径向强度和抗疲劳性能。聚合物替代品，包括可生物降解和不可生物降解的聚合物组合物，可作为临时支架，减轻长期植入负担，并方便未来的干预。材料创新也与涂层策略和药物释放型技术相结合，以塑造癒合反应和长期血管通畅性。

传统上，球囊扩张型系统用于需要精确部署和高径向力的情况，而自扩张平台则在曲折血管和动态血管段中提供了灵活性。这些差异会影响器械尺寸演算法、所需影像处理以及操作人员的学习曲线。临床应用领域多种多样，包括需要冠状动脉介入治疗的心血管疾病、需要管腔修復的胃肠道阻塞、需要精细颅内导航的神经血管疾病、支架支持肿瘤相关阻塞管理的肿瘤相关应用、以保肢和缓解症状为重点的周边动脉疾病，以及强调排尿和缓解阻塞的泌尿器官系统疾病。

终端用户环境进一步改变了产品需求和商业性模式。门诊手术中心和专科诊所需要能够缩短手术时间、简化物流并实现可预测恢復的设备。同时，医院和心臟中心优先考虑全面的产品系列、与复杂影像处理设备的整合以及对高度急性病例的强大支援。了解各个细分轴如何相互作用，对于根据特定相关人员的需求客製化临床证据产生、培训计划和商业模式至关重要。

影响美洲、中东和非洲以及亚太地区监管预期、临床采用模式和製造策略的区域动态

地理动态影响着美洲、欧洲、中东和非洲地区以及亚太地区的创新轨迹、监管要求和医疗服务提供者的采购惯例。在美洲，临床医生对微创介入心臟病学的熟悉程度以及主要器械製造商的高度集中，支持了产品的快速临床应用和迭代改进。法律规范强调可靠的临床数据和上市后监测，推动产品开发以长期疗效证据和性能一致性为导向。

欧洲、中东和非洲地区的监管协调工作并存，但地区差异会影响上市时间和当地临床实践模式。在这一广阔的地区，一些市场拥有强大的临床研究网络和先进的介入治疗能力，而其他市场则专注于扩大可及性和建立手术能力。该地区的医疗保健提供者通常会在成本与展示临床效用的愿望之间取得平衡，从而製定筹资策略和本地分销商模式。

亚太地区拥有多元化的医疗保健体系、在关键市场快速扩张的介入能力以及蓬勃发展的製造生态系统，以满足区域和全球需求。该地区的创新中心正在推动器材工程和成本敏感型大批量生产的进步。更广泛地说，每个地区都为临床伙伴关係、在地化製造投资以及反映报销结构、供应商能力和患者人口特征的独特市场开发方法提供了独特的机会。

现有企业、专业创新者和策略伙伴关係如何携手重新定义支架的竞争定位和长期差异化

支架领域的竞争态势反映出拥有广泛产品组合的成熟製造商与追求细分技术的新兴专业公司之间的平衡。主要企业持续投资于其核心平台的迭代改进，同时透过收购、共同开发契约和商业合作向邻近领域扩张。这些努力旨在扩大临床适应症，加速监管核准，并整合先进的影像和输送系统等互补技术。

中小型创新企业通常专注于研发专用材料、新型药物释放型化学技术或独特的递送机制，以满足尚未满足的临床需求或简化流程。成熟企业与创新企业之间的策略联盟日益普遍，这使得有前景的技术能够快速扩展，并共用。同时，契约製造製造商和零件供应商在加快产品上市速度和实现灵活生产方面发挥关键作用，尤其是在企业应对供应链压力的情况下。

商业性差异化将取决于能否展现长期患者获益，并提供以服务为导向的解决方案，例如培训计画、註册支援和绩效分析。成功将临床卓越性与营运支援和透明的价值沟通结合的公司，往往能够在大型医疗服务体系中获得优先地位。持续的併购、选择性的伙伴关係模式以及对上市后证据产生的投资，将在短期内塑造竞争地位。

为製造商和相关人员提供实用的策略处方笺，以增强供应弹性、临床差异化并获得支架的商业性价值

产业领导者应优先考虑多层面策略，将创新与供应链韧性和相关人员价值结合。首先，投资多元化采购和灵活的製造平台可以减少贸易中断的风险，并在采用加速的情况下帮助企业快速扩张。将部分业务外包，并与委託製造製造商建立策略伙伴关係关係，有助于保持成本竞争力，同时提高前置作业时间的可靠性。

其次，加快研究能显着改善长期临床疗效的材料和涂层，对于确保有利的采购地位至关重要。减少再血管再阻塞、降低併发症发生率以及简化再干预途径的证明，将引起付款方和大型医疗保健系统的共鸣。将强大的真实世界数据收集和登记纳入产品发布，将支持这些主张，并促进基于价值的合约谈判。

第三，透过设计满足门诊手术中心、专科诊所和重症监护医院特定需求的设备和服务模式，使商业性模式与最终用户环境保持一致。虽然门诊环境可能更倾向于简化的系统，以减少手术时间和物流负担，但三级医疗中心则需要全面的产品组合支援以及与影像生态系统的整合。

第四，积极应对不断变化的法规和报销问题，儘早与监管机构沟通，使临床项目与长期绩效目标保持一致，并製定透明的定价模型，以体现总体拥有成本 (TCO) 的效益。最后，在整个生态系统中建立伙伴关係关係，包括影像处理公司、数位医疗服务提供者和学术中心，建构将硬体与数据和服务相结合的平台解决方案，创造可防御的差异化优势和更强大的商业性价值提案。

一种透明且可复製的调查方法，结合临床医生访谈、监管和科学文献审查以及强大的三角测量来检验见解

调查方法将结构化的一手资料研究与系统的二次研究和严格的三角检验相结合，以确保信度和效度。一手资料研究包括对介入临床医生、采购负责人、监管专家和设备工程师的深入访谈，旨在揭示现实世界中的挑战、应用驱动因素以及未满足的临床需求。这些访谈提供了有关不同医疗环境中的程序工作流程、设备偏好和操作限制的背景资讯。

二次研究包括同行评审文献、监管指南文件、临床试验註册和企业资料披露信息，旨在揭示技术趋势、材料科学发展和竞争对手活动。公开的监管文件和指南有助于评估预期证据和核准途径。整合这些资讯来源使我们能够识别趋同讯号，并对供应链和商业性影响进行情境分析。

资料合成包括将访谈洞察与文献证据进行交叉检验，然后进行定性编码，以提取跨产品细分、材料、给药系统、临床应用和地理区域的主题模式。调查方法强调透明度和可重复性，并清楚记录关键假设和限制。开展了相关人员检验会议，以完善观察，确保其对商业和临床决策者俱有实际适用性。

全面了解临床证据、製造敏捷性和生态系统协作将如何决定不断发展的支架产业的竞争赢家

支架技术和商业化正进入实用创新阶段，临床有效性、营运可行性和供应链韧性将决定主导。材料和输送系统的进步正在拓展血管、神经血管、胃肠道和泌尿系统领域的治疗可能性，而监管和报销环境正将重点转向长期疗效和可证明的价值。医疗保健提供者和付款人越来越期望获得耐用性和成本效益的证据，这推动了对整合资料策略和结果主导产品定位的关注。

近期贸易政策变化和医疗服务提供者照护模式的转变，其累积效应凸显了自适应製造策略和精准商业性方法的重要性。将技术创新与韧性业务营运和清晰的价值创造相结合的公司，最有可能获得发展动力。从影像合作伙伴到学术网路再到支付方，整个生态系统的协作将加速技术应用，并支援向基于平台的解决方案转型，将设备与数据和服务相结合。

整体而言，未来将青睐那些将严谨的临床证据、敏捷的生产製造和以客户为中心的商业模式相结合，从而显着改善患者治疗效果并提升医疗服务提供者效率的组织。果断执行整合这些要素的策略的公司将创造持久的竞争优势。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合人工智慧引导成像，实现支架精准放置，减少手术併发症
  • 开发可生物降解的无聚合物药物释放型支架，最大限度地减少长期发炎反应
  • 镁合金生物吸收性的进步提供了更好的血管支持和逐渐吸收
  • 使用 3D 列印技术根据患者需求客製化支架形状，以优化动脉血流并最大程度降低血管再阻塞风险
  • 采用奈米涂层技术递送靶向抗增殖药物并防止新内膜增生
  • 主要市场的监管协调将加速新支架平台的核准和市场进入
  • 整合智慧支架感测器的新兴远端监控系统，用于即时血管再阻塞检测
  • 微创机器人输送系统扩大支架在周边动脉疾病的应用
  • 不断变化的报销政策对下一代药物释放型和生物可吸收支架采用率的影响
  • 透过经济高效的支架解决方案和本地製造伙伴关係扩大新兴市场渗透率

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章支架市场（依产品类型）

  • 冠状动脉支架
  • 胃肠道支架
  • 神经血管支架
    • 颅外颈动脉支架
    • 颅内支架
  • 週边动脉狭窄
    • 颈动脉支架
    • 股动脉支架
    • 髂动脉支架
    • 肾动脉支架
  • 泌尿系统支架
    • 摄护腺支架
    • 输尿管支架

第九章 支架市场（依材料）

  • 金属支架
    • 钴铬合金
    • 镍钛合金
    • 铂铬
    • 不銹钢
  • 聚合物支架
    • 可生物降解聚合物
    • 不可生物降解的聚合物

10. 支架市场（依交付方式）

  • 球囊扩张支架
  • 自动扩张型支架

第11章 支架市场（依应用）

  • 心血管疾病
  • 胃肠道阻塞
  • 神经血管疾病
  • 肿瘤学相关应用
  • 周边动脉疾病（PAD）
  • 泌尿系统疾病

第十二章 支架市场（依最终用户划分）

  • 门诊手术中心（ASC）
  • 心臟病中心
  • 医院
  • 专科诊所

第十三章 支架市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 支架市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国支架市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Cook Medical LLC
    • MicroPort Scientific Corporation
    • Lepu Medical Technology Co., Ltd.
    • Cordis Corporation
Product Code: MRR-434CCDA04EF3

The Stents Market is projected to grow by USD 25.33 billion at a CAGR of 7.73% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.95 billion
Estimated Year [2025] USD 15.01 billion
Forecast Year [2032] USD 25.33 billion
CAGR (%) 7.73%

A concise strategic overview of how clinical innovation, regulatory demands, and care delivery shifts are reshaping stents and interventional device strategies

The stents landscape occupies a pivotal role at the intersection of interventional medicine, device engineering, and health system economics. Advances in materials science, procedural techniques, and imaging technologies have broadened the therapeutic applications of stents beyond coronary interventions to encompass neurovascular, peripheral, gastrointestinal, and urological contexts. Clinicians increasingly favor minimally invasive options that shorten recovery, lower complication rates, and enable outpatient pathways, which in turn reshapes procurement priorities and care delivery models.

Industry participants operate within a complex regulatory and reimbursement environment that demands rigorous clinical evidence and post-market surveillance. Regulatory pathways now emphasize long-term safety and real-world performance, prompting manufacturers to integrate data generation into product strategies. Concurrently, provider systems are exploring value-based contracting and outcome-linked procurement, which raises the bar for comparative clinical benefit and cost-effectiveness.

This report synthesizes technological, clinical, and commercial signals to outline where innovation is creating differentiated value and where operational pressures are prompting strategic realignment. It intends to provide leaders with a clear baseline of contemporary dynamics, enabling them to prioritize investment, optimize supply chains, and refine go-to-market approaches in response to evolving stakeholder expectations.

How materials breakthroughs, design evolution, and commercial platform strategies are driving a paradigm shift in stents development and clinical adoption

The stents landscape is experiencing transformative shifts driven by converging forces across technology, regulation, and healthcare delivery. Materials innovation is redefining device performance as manufacturers move from traditional stainless steel constructs toward advanced alloys and polymer technologies that offer improved flexibility, radiopacity, and biological compatibility. These material advances enable lower-profile delivery systems and more precise deployment, which supports expansion into anatomically challenging indications and complex patient cohorts.

Concurrently, device design is aligning more closely with physiologic preservation and restenosis mitigation. Drug-eluting coatings, bioresorbable scaffolds, and surface engineering techniques aim to minimize neointimal proliferation while preserving vessel integrity. These design trends are complemented by improvements in imaging and navigation tools, which facilitate highly targeted interventions and reduce procedural variability. The interplay between device performance and procedural precision has important implications for training, procedural guidelines, and clinical adoption.

On the commercial front, consolidation among suppliers and strategic partnerships with technology firms are accelerating platform-based approaches that combine hardware with data-driven services. Reimbursement models are shifting toward value recognition, encouraging manufacturers to demonstrate long-term outcomes rather than focusing solely on peri-procedural metrics. At the same time, the provider landscape is decentralizing with greater adoption of ambulatory surgical centers and specialty clinics for selected procedures, prompting manufacturers to develop simplified systems and service models that support outpatient workflows.

Regulatory authorities are reinforcing post-market evidence requirements and real-world data collection, which increases the need for integrated registries and longitudinal follow-up. In response, manufacturers are investing in data infrastructure, remote monitoring, and stakeholder engagement strategies. In short, the industry is transitioning from single-product innovation toward integrated solutions that combine materials, procedural systems, data, and service models to deliver demonstrable clinical and economic value.

Assessment of how recent tariff policy changes are reshaping stents supply chains, manufacturing footprints, and commercial procurement dynamics across healthcare systems

The introduction of new tariff policies in the United States in 2025 has prompted a reassessment of global manufacturing, sourcing, and pricing strategies within the stents ecosystem. Supply chains that were previously optimized for cost and scale are experiencing renewed scrutiny as import levies affect component and finished-device economics. These tariff pressures have accelerated diversification of supplier bases and reignited interest in regional manufacturing to reduce exposure to cross-border trade volatility.

Manufacturers with vertically integrated capabilities or flexible production footprints have found it easier to adapt, while firms reliant on specialized overseas component suppliers have faced increased input cost volatility. In response, many companies are negotiating longer-term agreements, relocating certain manufacturing steps closer to end markets, and exploring toll-manufacturing arrangements to spread fixed costs and maintain continuity of supply. These operational moves are altering capital allocation decisions and influencing where R&D investments are directed.

Procurement teams within hospitals and health systems have also adjusted sourcing strategies to mitigate pass-through cost increases. Some providers have recalibrated device selection protocols and engaged in tighter contract negotiations, while others have pursued group purchasing arrangements to preserve access to preferred technologies. Payers and health technology assessors have been attentive to any implications for total procedure cost and long-term outcomes, which has amplified the need for transparency in pricing and demonstrated value propositions.

Importantly, the tariff environment has created an incentive for domestic and nearshore manufacturing investment, supporting policy conversations around medical device sovereignty and supply chain resilience. At the same time, the heightened cost environment may spur incremental innovation focused on materials efficiency, modular manufacturing, and reusable tooling. Overall, the cumulative impact of tariff changes is less a one-time shock and more a catalyst for structural shifts in sourcing, manufacturing strategy, and commercial engagement across the stents sector.

Insights into how product families, material choices, delivery systems, clinical use cases, and care settings collectively shape technology adoption and commercial strategy

Segment-level dynamics reveal differentiated demand drivers and distinct strategic priorities across product categories, materials, delivery modes, clinical applications, and end-user settings. Product diversity ranges from coronary stents focused on myocardial revascularization to gastrointestinal devices aimed at relieving luminal obstruction, neurovascular stents designed for carotid and intracranial applications, peripheral stents that address carotid, femoral, iliac, and renal arterial disease, as well as urological stents tailored to prostatic and ureteral indications. Each product family carries unique procedural requirements, regulatory considerations, and clinician training needs, which influences adoption timelines and clinical pathways.

Material choice exerts a foundational influence on device behavior, with metallic stents constructed from alloys such as cobalt chromium, nitinol, platinum chromium, and stainless steel delivering established radial strength and fatigue resistance for demanding vascular territories. Polymeric alternatives, including biodegradable and non-biodegradable polymer compositions, present opportunities for temporary scaffolding that could reduce long-term implant burden and facilitate future interventions. Material innovations also intersect with coating strategies and drug-elution technologies, shaping healing responses and long-term vessel patency profiles.

Mode of delivery is a central determinant of clinical use cases and procedure setting, with balloon-expandable systems traditionally used where precise deployment and high radial force are required, while self-expanding platforms offer conformability in tortuous or dynamic vascular segments. These differences impact device sizing algorithms, imaging requirements, and operator learning curves. Clinical application areas span cardiovascular disease leading to coronary interventions, gastrointestinal obstructions that require luminal patency restoration, neurovascular conditions demanding delicate intracranial navigation, oncology-related uses where stents support tumor-related obstruction management, peripheral artery disease where limb salvage and symptom alleviation are priorities, and urological disorders focusing on urinary drainage and obstruction relief.

End-user environments further modulate product requirements and commercial approaches. Ambulatory surgical centers and specialty clinics increasingly demand devices that enable shorter procedure times, simplified logistics, and predictable recovery, whereas hospitals and cardiology centers prioritize comprehensive product portfolios, integration with complex imaging suites, and robust support for high-acuity cases. Understanding how each segmentation axis interacts is essential for tailoring clinical evidence generation, training programs, and commercial models that align with specific stakeholder needs.

Regional dynamics affecting regulatory expectations, clinical adoption patterns, and manufacturing strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Geographic dynamics influence innovation trajectories, regulatory requirements, and provider procurement practices across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinician familiarity with minimally invasive cardiovascular interventions and a concentrated base of leading device manufacturers supports rapid clinical adoption and iterative product improvement. Regulatory frameworks emphasize robust clinical data and post-market surveillance, which steers product development toward long-term outcome evidence and performance consistency.

In Europe, the Middle East, and Africa, regulatory harmonization efforts coexist with regional variations that affect time-to-market and local clinical practice patterns. Several markets within this broad region demonstrate strong clinical research networks and advanced interventional capabilities, while others are focused on expanding access and building procedural capacity. Providers in this region often balance cost considerations with the desire for proven clinical benefit, shaping procurement strategies and local distributor models.

The Asia-Pacific landscape is characterized by diverse healthcare systems, rapidly expanding interventional capability in key markets, and an active manufacturing ecosystem that supplies both regional and global demand. Innovation hubs in this region are contributing to device engineering advances and high-volume, cost-sensitive production. More broadly, each region presents distinct opportunities for clinical partnerships, localized manufacturing investments, and tailored go-to-market approaches that reflect reimbursement structures, provider capabilities, and patient demographics.

How incumbent firms, specialized innovators, and strategic partnerships are converging to redefine competitive positioning and long term differentiation in stents

Competitive dynamics in the stents arena reflect a balance between entrenched manufacturers with broad portfolios and emerging specialists advancing niche technologies. Leading device companies continue to invest in iterative improvements to core platforms while seeking adjacent expansion through acquisitions, co-development agreements, and distribution partnerships. These efforts aim to broaden clinical indications, accelerate regulatory approvals, and integrate complementary technologies such as advanced imaging and delivery systems.

Smaller and mid-sized innovators often focus on specialized materials, novel drug-eluting chemistries, or unique delivery mechanisms that address unmet clinical needs or simplify procedures. Strategic collaborations between incumbents and innovators are increasingly common, enabling rapid scale-up of promising technologies and shared access to clinical trial networks. In parallel, contract manufacturers and component suppliers play a critical role in enabling speed-to-market and flexible production, especially as firms respond to supply chain pressures.

Commercial differentiation increasingly depends on demonstrating longitudinal patient benefits and offering service-oriented solutions such as training programs, registry support, and performance analytics. Companies that successfully combine clinical excellence with operational support and transparent value communication tend to gain preferential positioning with large provider systems. Continued M&A activity, selective partnership models, and investments in post-market evidence generation will shape competitive positioning in the near term.

Practical strategic prescriptions for manufacturers and stakeholders to strengthen supply resilience, clinical differentiation, and commercial value capture in stents

Industry leaders should prioritize a multi-dimensional strategy that aligns innovation with supply chain resilience and stakeholder value. First, investing in diversified sourcing and flexible manufacturing platforms reduces exposure to trade disruptions and supports rapid scaling when adoption accelerates. Nearshoring selected operations and developing strategic partnerships with contract manufacturers can preserve cost competitiveness while improving lead-time reliability.

Second, accelerating materials and coating research that demonstrably improves long-term clinical outcomes will be critical to securing favorable procurement positioning. Demonstrations of reduced restenosis, lower complication rates, and simplified reintervention pathways will resonate with payers and large provider systems. Integrating robust real-world data collection and registries into product launches will support these claims and facilitate value-based contracting discussions.

Third, tailor commercial approaches to end-user environments by designing devices and service models that meet the specific needs of ambulatory surgical centers, specialty clinics, and high-acuity hospitals. Simplified systems that reduce procedure time and logistics burden are likely to find traction in outpatient settings, while comprehensive portfolio support and integration with imaging ecosystems will be essential for tertiary centers.

Fourth, proactively address regulatory and reimbursement evolution by engaging early with authorities, aligning clinical programs to long-term performance endpoints, and preparing transparent pricing models that articulate total cost of care benefits. Finally, cultivate partnerships across the ecosystem - including imaging firms, digital health providers, and academic centers - to build platform solutions that combine hardware with data and services, thereby creating defensible differentiation and stronger commercial value propositions.

A transparent and reproducible methodology combining clinician interviews, regulatory and scientific literature review, and robust triangulation to validate insights

The research approach combined structured primary inquiry, systematic secondary review, and rigorous triangulation to ensure reliability and relevance. Primary research consisted of in-depth interviews with interventional clinicians, procurement leaders, regulatory experts, and device engineers to surface real-world challenges, adoption drivers, and unmet clinical needs. These conversations provided context on procedural workflows, device preferences, and the operational constraints of different care settings.

Secondary research included peer-reviewed literature, regulatory guidance documents, clinical trial registries, and company disclosures to map technological trends, material science developments, and competitive activities. Publicly available regulatory filings and guidance informed the assessment of evidence expectations and approval pathways. The integration of these sources enabled identification of convergent signals and informed scenario analysis around supply chain and commercial impacts.

Data synthesis involved cross-validation between interview insights and documentary evidence, followed by qualitative coding to extract thematic patterns across product segments, materials, delivery systems, clinical applications, and geographic regions. The methodology emphasized transparency and reproducibility, with key assumptions and limitations explicitly documented. Stakeholder validation sessions were conducted to refine findings and ensure practical applicability for commercial and clinical decision-makers.

Synthesis of how clinical evidence, manufacturing agility, and ecosystem collaboration will determine competitive winners in the evolving stents landscape

Stents technology and commercialization are entering a phase of pragmatic innovation where clinical efficacy, operational feasibility, and supply chain resilience will determine leadership. Advances in materials and delivery systems are expanding therapeutic possibilities across vascular, neurovascular, gastrointestinal, and urological domains, while regulatory and reimbursement environments are shifting focus toward long-term outcomes and demonstrable value. Providers and payers increasingly expect evidence of durability and cost-efficiency, which places a premium on integrated data strategies and outcome-driven product positioning.

The cumulative effect of recent trade policy shifts and changing provider care models underscores the importance of adaptive manufacturing strategies and targeted commercial approaches. Firms that align technical innovation with resilient operations and clear value articulation will be best positioned to capture momentum. Collaboration across the ecosystem - from imaging partners to academic networks and payers - will accelerate adoption and support the shift toward platform-based solutions that combine devices with data and services.

Overall, the period ahead favors organizations that combine rigorous clinical evidence, agile manufacturing, and customer-centric commercial models to deliver measurable improvements in patient outcomes and provider efficiency. Those who act decisively to integrate these elements into cohesive strategies will create enduring competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence-guided imaging for precise stent placement to reduce procedural complications
  • 5.2. Development of biodegradable polymer-free drug-eluting stents to minimize long-term inflammatory response
  • 5.3. Advances in magnesium alloy bioresorbable stents offering improved vessel support and gradual absorption
  • 5.4. Use of 3D printing for patient-specific stent geometries to optimize arterial flow and minimize restenosis risk
  • 5.5. Adoption of nanocoating technologies to deliver targeted anti-proliferative drugs and prevent neointimal hyperplasia
  • 5.6. Regulatory harmonization across major markets accelerating approval and market entry of novel stent platforms
  • 5.7. Emergence of remote monitoring systems integrated with smart stent sensors for real-time restenosis detection
  • 5.8. Growth of stent applications in peripheral artery disease driven by minimally invasive robotic-assisted delivery systems
  • 5.9. Impact of evolving reimbursement policies on adoption rates of next-generation drug-eluting and bioabsorbable stents
  • 5.10. Expansion of emerging markets penetration through cost-effective stent solutions and localized manufacturing partnerships

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Stents Market, by Product Type

  • 8.1. Coronary Stents
  • 8.2. Gastrointestinal Stents
  • 8.3. Neurovascular Stents
    • 8.3.1. Extracranial Carotid Artery Stents
    • 8.3.2. Intracranial Stents
  • 8.4. Peripheral Stents
    • 8.4.1. Carotid Artery Stents
    • 8.4.2. Femoral Artery Stents
    • 8.4.3. Iliac Artery Stents
    • 8.4.4. Renal Artery Stents
  • 8.5. Urological Stents
    • 8.5.1. Prostatic Stents
    • 8.5.2. Ureteral Stents

9. Stents Market, by Material

  • 9.1. Metallic Stents
    • 9.1.1. Cobalt Chromium
    • 9.1.2. Nitinol
    • 9.1.3. Platinum Chromium
    • 9.1.4. Stainless Steel
  • 9.2. Polymeric Stents
    • 9.2.1. Biodegradable Polymers
    • 9.2.2. Non-biodegradable Polymers

10. Stents Market, by Mode of Delivery

  • 10.1. Balloon-Expandable Stents
  • 10.2. Self-Expanding Stents

11. Stents Market, by Application

  • 11.1. Cardiovascular Diseases
  • 11.2. Gastrointestinal Obstructions
  • 11.3. Neurovascular Conditions
  • 11.4. Oncology-Related Applications
  • 11.5. Peripheral Artery Disease (PAD)
  • 11.6. Urological Disorders

12. Stents Market, by End User

  • 12.1. Ambulatory Surgical Centers (ASCs)
  • 12.2. Cardiology Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Medtronic plc
    • 16.3.3. Boston Scientific Corporation
    • 16.3.4. Terumo Corporation
    • 16.3.5. B. Braun Melsungen AG
    • 16.3.6. Biotronik SE & Co. KG
    • 16.3.7. Cook Medical LLC
    • 16.3.8. MicroPort Scientific Corporation
    • 16.3.9. Lepu Medical Technology Co., Ltd.
    • 16.3.10. Cordis Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 336. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 337. MIDDLE EAST STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. MIDDLE EAST STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. MIDDLE EAST STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 340. MIDDLE EAST STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 341. MIDDLE EAST STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 342. MIDDLE EAST STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 343. MIDDLE EAST STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 344. MIDDLE EAST STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 345. MIDDLE EAST STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 346. MIDDLE EAST STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 347. MIDDLE EAST STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 348. MIDDLE EAST STENTS MARKET SIZE, BY METALLIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 349. MIDDLE EAST STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2024 (USD MILLION)
  • TABLE 350. MIDDLE EAST STENTS MARKET SIZE, BY POLYMERIC STENTS, 2025-2032 (USD MILLION)
  • TABLE 351. MIDDLE EAST STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 352. MIDDLE EAST STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 353. MIDDLE EAST STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 354. MIDDLE EAST STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 355. MIDDLE